Patient Rating:

4.7 out of 5

33 Patient Ratings
17 Patient Comments

Ying J. Hitchcock, M.D.

Patient Rating:

4.7 out of 5

33 Patient Ratings
17 Patient Comments

Clinical Details

Phone Number Clinical Office Address
(801) 581-2396 Huntsman Cancer Hospital
Radiation Oncology
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

Ying Hitchcock, MD, is an associate professor in the Department of Radiation Oncology, specializing in head and neck, lung, and skin cancers and in adult soft tissue sarcomas. She is also a Principle Investigator for both Huntsman Cancer Institute and Radiation Therapy Oncology Group (RTOG) studies. She treats all forms of cancer in her practice.

Hitchcock served as the department’s Residency Program Director from 2004 to 2012. In this capacity, she received the Outstanding Teacher of the Year Award from the Association of Residents in Radiation Oncology (ARRO) twice, for the 2006-2007 and 2008-2009 academic years.

Hitchcock received a medical degree from the Peking Union Medical College Graduate School in Beijing, China, where she specialized in head and neck surgery. She completed an internship in general surgery at the State University of New York at Buffalo Graduate Medical-Dental Education Consortium and a residency in radiation oncology at the Roswell Park Cancer Institute, also in Buffalo.

Board Certification and Academic Information

Academic Departments Radiation Oncology - Associate Professor (Clinical)
Board Certification American Board of Radiology (Radiation Oncology)
American Board of Radiology (Radiation Oncology)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.8
My confidence in care provider
4.8
Time care provider spent with me
4.7
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.7
Care provider's concern for questions & worries
4.7
Care provider's explanation of condition/problem
4.7
Wait time at clinic
4.7
Care provider's friendliness and courtesy
4.9

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

January 05, 2015

Dr. Hitchcock and Dr. Ly both were highly informative in responding to our questions.

November 16, 2014

I have already recommended Dr. Hitchcock and HCI to others, and will continue to do so. She is a great doctor.

September 26, 2014

All staff contact was was pleasant and professional. I felt the staff cared about my welfare.

August 22, 2014

Alrhough a bit tough to understand her Dr. Hitcock is so helpful in her explanations and so encouraging. she really seems to know what she is doing and instills confindence in her patients that they are on the road to recovery.

July 18, 2014

Nothing short of perfection, but perfection done out of a want to help everyone entering the Huntsman Facility from a visitor to someone with the most special of needs (I am certain you get my point)!

July 13, 2014

As always, Dr. Hitchcock and her team treat me Professionally, but with personal interest in my care. These and the entire Huntsman staff are world class.

July 13, 2014

Dr. Hitchcock could not be any better.

May 31, 2014

We have already shared with everyone who asks just how caring everyone at The Huntsman is and what great care we are receiving. We are grateful that we were able to get in.

April 06, 2014

I greatly appreciate the compassion & reassurance the staff showed for my situation. Out of state travel is difficult & the doctor was so amiable with me receiving treatment closer to home.

December 12, 2013

All good.

May 03, 2013

Dr. Hitchcock was excellent. The resident that was working with her the day of our visit needs to pay attention to Dr Hitchcock. He did not want to hear our questions, and infact told us to not ask any questions and just listen to what he had to say. Poor patient interaction with the resident.

April 18, 2013

very amazing experience

March 08, 2013

she didn't patronize me...but acknowedged. This was a follow-up and my treatment was done elsewhere. I have a great deal of confidence that she will take what has begun and continue this journey well.

January 22, 2013

outstanding!

January 21, 2013

good

October 22, 2012

I am very well plelased with everything you folks have done

October 01, 2012

Both Dr. Hitchcock and the resident were very informed about my case, interested, and closely tracking the results of my course of treatment. First Class all the way.

Academic Profile

Board Certification and Academic Information

Academic Departments Radiation Oncology - Associate Professor (Clinical)
Board Certification American Board of Radiology (Radiation Oncology)
American Board of Radiology (Radiation Oncology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-2396 Huntsman Cancer Hospital
Radiation Oncology
1950 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Ying Hitchcock, MD, is an associate professor in the Department of Radiation Oncology, specializing in head and neck, lung, and skin cancers and in adult soft tissue sarcomas. She is also a Principle Investigator for both Huntsman Cancer Institute and Radiation Therapy Oncology Group (RTOG) studies. She treats all forms of cancer in her practice.

Hitchcock has served as the department’s Residency Program Director since 2004. In this capacity, she has received the Outstanding Teacher of the Year Award from the Association of Residents in Radiation Oncology (ARRO) twice, for the 2006-2007 and 2008-2009 academic years.

Hitchcock received a medical degree from the Peking Union Medical College Graduate School in Beijing, China, where she specialized in head and neck surgery. She completed an internship in general surgery at the State University of New York at Buffalo Graduate Medical-Dental Education Consortium and a residency in radiation oncology at the Roswell Park Cancer Institute, also in Buffalo.

Education

Education History

Type School Degree
Residency Roswell Park Cancer Institute
Radiation Oncology
Resident
Internship SUNY - Buffalo
General Surgery
Intern
Professional Medical Peking Union Medical College
Head & Neck Surgery
M.D.
Graduate Training The 4th Military Medical University
Medicine
M.S.
Residency The 4th Military Medical University
Otolaryngology
Resident
Undergraduate The 4th Military Medical University
Medicine
B.S.

Publications

Selected Provider Publications

Journal Article

  1. Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK, Dundas G, Kirsch DG (2015). Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. J Clin Oncol, 33(20), 2231-8.
  2. Chen AC, Anker CJ, Hunt JP, Buchmann LO, Grossmann KF, Boucher K, Fang LC, Shrieve DC, Hitchcock YJ (2015). Clinical Outcomes Associated with Evolving Treatment Modalities and Radiation Techniques for Base of Tongue Carcinoma: Thirty Years of Institutional Experience. Cancer Med, 4(5), 651-60.
  3. Zang J, Li C, Luo SQ, Wang JH, Xu M, Zhao LN, Li WW, Yang H, Xiao F, Hitchcock YJ, Shi M (2015). Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience. Ann Hematol, 94(4), 583-91.
  4. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M (2014). Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw, 12(10), 1454-87.
  5. Terakedis BE, Hunt JP, Buchmann LO, Avizonis VN, Anker CJ, Hitchcock YJ (2014). The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland. (Epub ahead of print) Am J Clin Oncol.
  6. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA (2014). RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol, 4(2), 76-81.
  7. Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC (2014). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. J Am Acad Dermatol, 70(3), 435-42.
  8. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M (2013). Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 11(8), 917-23.
  9. Sarkar V, Wang B, Hinkle J, Gonzalez VJ, Hitchcock YJ, Rassiah-Szegedi P, Joshi S, Salter BJ (2012). Dosimetric evaluation of a "virtual" image-guidance alternative to explicit 6 degree of freedom robotic couch correction. Pract Radiat Oncol, 2(2), 122-37.
  10. Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, Gaffney D (2012). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol, 7, 64.
  11. Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F (2012). Mucosal melanoma of the head and neck. J Natl Compr Canc Netw, 10(3), 320-38.
  12. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA (2011). RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. Int J Radiat Oncol Biol Phys, 81(2), S131-S132.
  13. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Kirsch DG, Hitchcock, YJ, Wolfson AH, DeLaney TF (2011). RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomograhic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys, 81(4), e525-8.
  14. Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F (2011). Head and neck cancers. J Natl Compr Canc Netw, 9(6), 596-650.
  15. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD (2011). Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck, 33(5), 645-9.
  16. Sampath S, Schultheiss TE, Hitchcock YJ, Randall RL, Shrieve DC, Wong JY (2011). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys, 81(2), 498-505.
  17. Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ (2011). IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys, 81(5), e845-52.
  18. Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Hitchcock YJ, Wolfson AH, DeLaney TF (2011). Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys, 81(5), e775-80.
  19. Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY (2010). Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol, 101(5), 345-50.
  20. Anker CJ, Wang B, Tobler M, Chapek J, Shrieve DC, Hitchcock YJ, Salter BJ (2010). Evaluation of fluence-smoothing feature for three IMRT planning systems. J Appl Clin Med Phys, 11(2), 3035.
  21. Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA (2009). Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med, 50(8), 1205-13.
  22. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2009). Relative contributions of radiation and cisplatin-based chemotherapy to seneorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys, 73(3), 779-88.
  23. Chen J, Tward JD, Shrieve DC, Hitchcock YJ (2008). Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. Am J Clin Oncol, 31(5), 460-4.
  24. Wallace S, Pilon A, Kwok P, Messner LV, Hitchcock YJ (2008). Ophthalmic manifestations of an undifferentiated sinonasal carcinoma. Optom Vis Sci, 85(4), 226-9.
  25. Skidmore T, Lee C, Abbott T, Wiggins R, Anderson G, Hitchcock YJ (2008). Progressive Bone Loss Gorhma's Disease. Ear Nose Throat J, 87(6), E4-7.
  26. Chen J, Shrieve DC, Hitchcock YJ (2008). Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer. Radiother Oncol, 87(2), 274-80.
  27. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD (2008). The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab, 93(2), 504-15.
  28. Hitchcock YJ, Bentz BG, Sharma PK, Fang C, Tward JD, Pappas L, Chen J, Hayes JK, Shrieve DC (2007). Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers. Otolaryngol Head Neck Surg, 137(3), 422-7.
  29. Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, Fang LC, Hayes JK, Shrieve DC, Hitchcock YJ (2007). Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck, 29(4), 362-9.
  30. Randall RL, Schabel KL, Hitchcock YJ, Joyner DE, Albritton KH (2005). Diagnosis and management of synovial sarcoma. Curr Treat Options Oncol, 6(6), 449-59.
  31. Hitchcock YJ, Chen J, Sharma P, Moeller J, et al (2005). Iridium-192 interstitial brachytherapy for squamous cell carcinoma of the oral tongue. Brachytherapy, 4, 96.
  32. Pidhorecky I, Lee RJ, Proulx G, Kollmorgen DR, Jia CY, Driscoll DL, Kraybill WG, Gibbs JF (2001). Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol, 8(2), 109-15.
  33. Warnakulasuriya S, Jia CY, Johnson N, Houghton J (2000). p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy. J Pathol, 191(1), 33-38.
  34. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia CY, Kraybill WG (2000). Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys, 46(2), 467-474.
  35. Tu GY, Tang PZ, Jia CY (1997). Horizontovertical laryngectomy for supraglottic carcinoma. Otolaryngol Head Neck Surg, 117(3 pt 1), 280-286.
  36. Tu GY, Jia CY (1994). How do I do it? Surgical approach for parapharyngeal space recurrence of the nasopharyngeal carinoma after failure of high dose radiation therapy. Arch Otolaryngol Head Neck Surg, 1, 191-192.
  37. Jia CY, Want J, Qian W, et al (1994). The relationship between amplication of c-myc oncogene and squamous cell carcinoma of the larynx. Clin Otolaryngol, 8, 70-71.
  38. Herde RF, Kokeny KE, Reddy CB, Akerley WA, Hu N, Boltax JP, Hitchcock YJ (In Press). Primary pulmonary carcinoid tumor: a long-term single institution experience. Am J Clin Oncol.

Book Chapter

  1. Gaffney DK, Shrieve DC, Anker CJ, Buyyounouski MK, Kong FM, Hitchcock YJ, Tward JD (12/19/2012). Paranasal Sinus Cancer; Oral Cavity Cancer. In Radiation Oncology: Imaging and Treatment (p. 808). Amirsys.

Conference Proceedings

  1. Hitchcock YJ, Kurtz A, Zhou H, Randall L (2005). Radiation induced sarcomas in long term cancer survivors. 11th Annual Connective Tissue Oncology Society, Boca Raton: 11th Annual Connective Tissue Oncology Society.
  2. Hitchcock YJ, Bentz B, Fang C, Shrieve D, Sharma P (2005). Does chemotherapy change the role of planned neck dissection? - Single instituion experience in neck management of squamous cell carcinoma of the base of tongue treated with definitive radition therapy with or without chemotherapy. Radiological Society of North America, Radiological Society of North America.
  3. Hitchcock YJ, Chen J, Sharma P, Moeller J, et al (2005). Iridium-192 interstitial brachytherapy for squamous cell carcinoma of the oral tongue. The 26th Annual Meeting of the American Brachytherapy Society, San Francisco: Brachytherapy.
  4. Hitchcock YJ, Bentz B, Jensen R, Sharma P (2004). Second high-grade sarcoma of the mandible within prophylactic cranial irradiation field in a long-term survivor of childhood acute lymphocytic leukemia. 10th Annual Connective Tissue Oncology Society, Montreal, Quebec: 10th Annual Connective Tissue Oncology Society in Montreal.
  5. Hitchcock YJ, Chern Shyh-Shi, Chapek J, Williams G, Albritton K, Randall L, Gaffney D, Leavitt D (2004). Intensity modulated radiotherapy for large abdominal or retroperitoneal connective tissue tumors. 10th Annual Connective Tissue Oncology Society, Montreal, Quebec: 10th Annual Connective Tissue Oncology Society in Montreal.

Letter

  1. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Delaney TF, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH (2012). In Reply to O'Sullivan et al [Letter to the editor]. Int J Radiat Oncol Biol Phys, 84(2), 307-8.
  2. Hitchcock YJ, Proulx GM, Stomper PC (2002). Contrast-enhanced MRI for the assessment of local recurrence after breast conservation [Letter to the editor]. Am J Clin Oncol, 25(4), 428-9.

Abstract

  1. Hitchcock YJ, Macdonald K, Lessnick S, Chen L, Chen J, Randall L (2007). Alveolar soft part sarcoma - Demographic, clinical and pathologic predictors of survival from the surveillance, epidemiology and end results (SEER) database [Abstract]. International Journal of Radation Oncology Biology Physics, 69(3), S754-55.
  2. Salter BJ, Anker CJ, Tobler M, Hitchcock YJ (2007). Optimization of IMRT fluence-map smoothing can result in improved IMRT plans [Abstract]. International Journal of Radiation Oncology Biology Physics, 69(3), S681.
  3. Brow AP, Tward JD, Shrieve DC, Hitchcock YJ (2006). The risk of development and factors affecting the pattern of secondary cancers following thyroid cancer diagnosis [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S434.
  4. Chen J, Shrieve DC, Hitchcock YJ (2006). Comparison of cervial esophagus dose-volumes and three radiotherapy techniques for head and neck cancer [Abstract]. International Journal for Radiation Oncology Biology Physics, 66(3), S432-433.
  5. Hitchcock YJ, Morton K, Tward JD, Hoffman JM, Sharma P, Bentz B, Shrieve DC (2006). The Application of [FDG] PET/CT in treatment planning and response evaluation for patients undergoing radiotherapy for head and neck cancer [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S443-434.
  6. Tward JD, Szabo A, Orlandi R, Dahlstrom L, Shrieve DC, Hitchcock YJ (2006). Relative contributions of Radiation and platinum-based chemotherapy to sensorineural hearing loss in head and neck cancer patients [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S188.
  7. Hitchcock YJ, Proulx G (2001). Renal function after definitive radiation therapy for pancreatic cancer [Abstract]. International Journal of Radiation Oncology Biology Physics, 51(2278a), 369.
  8. Lee RJ, Gibbs JF, Kollmorgen DR, Proulx GM, Jia CY, Driscoll DL, Kraybill WG (1998). Prognostic factors in patients undergoing lymph node dissection for node-positive melanoma: implication for adjuvant radiotherapy [Abstract]. International Journal of Radiation Oncology, Biology, and Physics, 42, 385.

Other

  1. Jia CY (1995). The relation between Myc gene family and had and neck cancer. Foreign Medical Sciences (19, pp. 4-6).

Poster

  1. Citrin DE, Hitchcock YJ, CHung E, Frandsen J, Urick M, Shield W, Vaswani S, Gaffney D (2011). Evaluation of Cytokine Protein Levels in Secretions of Patients Undergoing Radiotherapy as a Novel Non-Invasive Biomarker. Poster session presented at 3B Research Forum Benchtop to Bedside an Back, ASTRO.
  2. Salter BJ, Wang B, Ruhnau S, Hinkle J, Sarang J, Sarkar V, Sadinski M, Hitchcock YJ, Kokeny KE, Shrieve DC (2011). VALIDATION OF INTERNAL TARGET VOLUME (ITV) CONSISTENCY, USING 4DCT FOR LUNG SBRT TREATMENTS. Poster session presented at International Stereotactic Radiosurgery Society, Paris.
  3. Pidhorecky I, Gibbs J, Kollmorgen D, Lee J, Jia CY, Kraybill W (2001). Risk factor for nodal recurrence after lymphadenectomy for melanoma. Poster session presented at 53rd Annual Meeting of the Society of Surgical Oncology.
  4. Proulx G, Plunkett R, Lee RJ, Jia CY, Mechtler L, Podgorsak MB, Fenstermaker R (1999). Stereotactic radiosurgery for recurrent high grade glioma. Poster session presented at American Radium Society.

Clinical Trials

Video & News